Trials / Unknown
UnknownNCT05953974
Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators wish to test a diagnostic risk score for autoimmune encephalitis in case of encephalitis, previously validated by two American teams, in a retrospective analysis, according to the clinical and paraclinical data available in our database of the Reference Centre for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of Professor Honnorat for patients with NMDAr, anti LGi1, anti CASPR2, anti GABAbr and anti GAD antibodies.
Conditions
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Clinical score of Granillo and al. | Compare the performance of the clinical prediction score of confirmed autoimmune encephalitis according to the type of antibody isolated from the CSF. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-02-01
- Completion
- 2023-12-30
- First posted
- 2023-07-20
- Last updated
- 2023-11-13
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05953974. Inclusion in this directory is not an endorsement.